These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14514601)

  • 1. Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPARgamma gene and type 2 diabetes.
    Memisoglu A; Hu FB; Hankinson SE; Liu S; Meigs JB; Altshuler DM; Hunter DJ; Manson JE
    Diabetes Care; 2003 Oct; 26(10):2915-7. PubMed ID: 14514601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is a Pro12Ala polymorphism of the PPARgamma2 gene related to obesity and type 2 diabetes mellitus in the Czech population?
    Srámková D; Kunesová M; Hainer V; Hill M; Vcelák J; Bendlová B
    Ann N Y Acad Sci; 2002 Jun; 967():265-73. PubMed ID: 12079854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.
    Altshuler D; Hirschhorn JN; Klannemark M; Lindgren CM; Vohl MC; Nemesh J; Lane CR; Schaffner SF; Bolk S; Brewer C; Tuomi T; Gaudet D; Hudson TJ; Daly M; Groop L; Lander ES
    Nat Genet; 2000 Sep; 26(1):76-80. PubMed ID: 10973253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
    Ringel J; Engeli S; Distler A; Sharma AM
    Biochem Biophys Res Commun; 1999 Jan; 254(2):450-3. PubMed ID: 9918859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.
    Lindi VI; Uusitupa MI; Lindström J; Louheranta A; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Laakso M; Tuomilehto J;
    Diabetes; 2002 Aug; 51(8):2581-6. PubMed ID: 12145174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass.
    Memisoglu A; Hu FB; Hankinson SE; Manson JE; De Vivo I; Willett WC; Hunter DJ
    Hum Mol Genet; 2003 Nov; 12(22):2923-9. PubMed ID: 14506127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
    Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
    Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes.
    Caramori ML; Canani LH; Costa LA; Gross JL
    Diabetes; 2003 Dec; 52(12):3010-3. PubMed ID: 14633865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome.
    Frederiksen L; Brødbaek K; Fenger M; Jørgensen T; Borch-Johnsen K; Madsbad S; Urhammer SA
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3989-92. PubMed ID: 12161548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
    Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association of the codon 12 polymorphism of the peroxisome proliferator-activated receptor gamma gene with breast cancer and body mass.
    Memisoglu A; Hankinson SE; Manson JE; Colditz GA; Hunter DJ
    Pharmacogenetics; 2002 Nov; 12(8):597-603. PubMed ID: 12439219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PPAR{gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas.
    Gong Z; Xie D; Deng Z; Bostick RM; Muga SJ; Hurley TG; Hebert JR
    Carcinogenesis; 2005 Mar; 26(3):579-85. PubMed ID: 15564289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight.
    Doney A; Fischer B; Frew D; Cumming A; Flavell DM; World M; Montgomery HE; Boyle D; Morris A; Palmer CN
    BMC Genet; 2002 Nov; 3():21. PubMed ID: 12429071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation at the adiponectin locus and risk of type 2 diabetes in women.
    Hu FB; Doria A; Li T; Meigs JB; Liu S; Memisoglu A; Hunter D; Manson JE
    Diabetes; 2004 Jan; 53(1):209-13. PubMed ID: 14693717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of polymorphism pro12Ala of PPARgamma gene on endothelium destruction in patients with diabetes mellitus t. 2].
    Gacka M; Dobosz T; Szymaniec S; Bednarska-Chabowska D; Adamiec R
    Pol Arch Med Wewn; 2005 Nov; 114(5):1055-65. PubMed ID: 16789503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects.
    Koch M; Rett K; Maerker E; Volk A; Haist K; Deninger M; Renn W; Häring HU
    Diabetologia; 1999 Jun; 42(6):758-62. PubMed ID: 10382597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
    Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
    Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients.
    Zietz B; Barth N; Spiegel D; Schmitz G; Schölmerich J; Schäffler A
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):60-6. PubMed ID: 11928067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.
    Niskanen L; Lindi V; Erkkilä A; Sivenius K; Luoma J; Ylä-Herttuala S; Laakso M; Uusitupa MI
    Metabolism; 2003 Feb; 52(2):213-7. PubMed ID: 12601635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction.
    Ridker PM; Cook NR; Cheng S; Erlich HA; Lindpaintner K; Plutzky J; Zee RY
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):859-63. PubMed ID: 12663371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.